Resultados de procura - C. Allison Stewart
- Mostrando 1 - 19 Resultados de 19
-
1
-
2
-
3
CTNNB1 in Mesenchyme Regulates Epithelial Cell Differentiation during Müllerian Duct and Postnatal Uterine Development por C. Allison Stewart, Ying Wang, Margarita Bonilla-Claudio, James F. Martin, Gabriel González, Makoto M. Taketo, Richard R. Behringer
Publicado 2013Artigo -
4
Uterine Gland Formation in Mice Is a Continuous Process, Requiring the Ovary after Puberty, But Not after Parturition1 por C. Allison Stewart, Sara J. Fisher, Ying Wang, M. Stewart, Sylvia C. Hewitt, Karina F. Rodriguez, Kenneth S. Korach, Richard R. Behringer
Publicado 2011Artigo -
5
-
6
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer por Robert J. Cardnell, Ying Feng, Seema Mukherjee, Lixia Diao, Pan Tong, C. Allison Stewart, Fatemeh Masrorpour, You-Hong Fan, Monique B. Nilsson, Yuqiao Shen, John V. Heymach, Jing Wang, Lauren A. Byers
Publicado 2016Artigo -
7
Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora por Ken Blount, Cynthia M. Megyola, Mark S. Plummer, David G. Osterman, Tim O’Connell, Paul A. Aristoff, Cheryl L. Quinn, R. Alan Chrusciel, Toni J. Poel, Heinrich J. Schostarez, C. Allison Stewart, Daniel P. Walker, Peter G. M. Wuts, Ronald R. Breaker
Publicado 2015Artigo -
8
Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy por Jo Ann Janovick, M. Stewart, Darla Jacob, L. Martin, Jian Min Deng, C. Allison Stewart, Ying Wang, Anda Cornea, Lakshmi Chavali, Suhujey Lopez, Shoukhrat Mitalipov, Eunju Kang, Hyosang Lee, Pulak R. Manna, Douglas M. Stocco, Richard R. Behringer, P. Michael Conn
Publicado 2013Artigo -
9
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer por Kasey R. Cargill, C. Allison Stewart, Elizabeth M. Park, Kavya Ramkumar, Carl M. Gay, Robert J. Cardnell, Qi Wang, Lixia Diao, Li Shen, You-Hong Fan, Wai Kin Chan, Philip L. Lorenzi, Trudy G. Oliver, Jing Wang, Lauren A. Byers
Publicado 2021Artigo -
10
CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib por Triparna Sen, Pan Tong, C. Allison Stewart, Sandra Cristea, Aly Valliani, David S. Shames, Abena B. Redwood, You Hong Fan, Lerong Li, Bonnie S. Glisson, John D. Minna, Julien Sage, Don L. Gibbons, Helen Piwnica‐Worms, John V. Heymach, Jing Wang, Lauren A. Byers
Publicado 2017Artigo -
11
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironme... por Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic, Robert J. Cardnell, Lixia Diao, Kavya Ramkumar, Carl M. Gay, C. Allison Stewart, You-Hong Fan, Li Shen, Ryan J. Hansen, Bryan Strouse, Michael P. Hedrick, Christian A. Hassig, John V. Heymach, Jing Wang, Lauren A. Byers
Publicado 2019Artigo -
12
AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors por Kavya Ramkumar, C. Allison Stewart, Kasey R. Cargill, Carminia Maria Della Corte, Qi Wang, Li Shen, Lixia Diao, Robert J. Cardnell, David H. Peng, B. Leticia Rodriguez, You-Hong Fan, John V. Heymach, Jing Wang, Carl M. Gay, Don L. Gibbons, Lauren A. Byers
Publicado 2020Artigo -
13
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer por Benjamin B. Morris, Simon Heeke, Yuanxin Xi, Lixia Diao, Qi Wang, Pedro Rocha, Edurne Arriola, Myung Chang Lee, Darren R. Tyson, Kyle Concannon, Kavya Ramkumar, C. Allison Stewart, Robert J. Cardnell, Runsheng Wang, Vito Quaranta, Jing Wang, John V. Heymach, Barzin Y. Nabet, David S. Shames, Carl M. Gay, Lauren A. Byers
Publicado 2025Artigo -
14
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer por C. Allison Stewart, Pan Tong, Robert J. Cardnell, Triparna Sen, Lerong Li, Carl M. Gay, Fatemah Masrorpour, You Hong Fan, Rasha O. Bara, Ying Feng, Yuanbin Ru, Junya Fujimoto, Samrat T. Kundu, Leonard Post, Karen Yu, Yuqiao Shen, Bonnie S. Glisson, Ignacio I. Wistuba, John V. Heymach, Don L. Gibbons, Jing Wang, Lauren A. Byers
Publicado 2017Artigo -
15
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer por C. Allison Stewart, Carl M. Gay, Yuanxin Xi, Santhosh Sivajothi, V. Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M. Hartsfield, Veerakumar Balasubramaniyan, Milind D. Chalishazar, César A. Moran, Neda Kalhor, John Stewart, Hai T. Tran, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, John de Groot, Bonnie S. Glisson, Trudy G. Oliver, John V. Heymach, Ignacio I. Wistuba, Paul Robson, Jing Wang, Lauren A. Byers
Publicado 2020Artigo -
16
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype por Carminia Maria Della Corte, Triparna Sen, Carl M. Gay, Kavya Ramkumar, Lixia Diao, Robert J. Cardnell, B. Leticia Rodriguez, C. Allison Stewart, Vassiliki A. Papadimitrakopoulou, Laura Gibson, Jared J. Fradette, Qi Wang, You-Hong Fan, David H. Peng, Marcelo V. Negrão, Ignacio I. Wistuba, Junya Fujimoto, Luisa M. Solis Soto, Carmen Behrens, Ferdinandos Skoulidis, John V. Heymach, Jing Wang, Don L. Gibbons, Lauren A. Byers
Publicado 2020Artigo -
17
Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer por Huang Fang, Kenneth E. Huffman, Zixi Wang, Xun Wang, Kailong Li, Feng Cai, Chendong Yang, Ling Cai, Terry S. Shih, Lauren G. Zacharias, Andrew Chung, Qian Yang, Milind D. Chalishazar, Abbie S. Ireland, C. Allison Stewart, Kasey R. Cargill, Luc Girard, Yi Liu, Min Ni, Jian Xu, Xudong Wu, Hao Zhu, Benjamin J. Drapkin, Lauren A. Byers, Trudy G. Oliver, Adi F. Gazdar, John D. Minna, Ralph J. DeBerardinis
Publicado 2020Artigo -
18
Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology por C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson, Simon Heeke, Elizabeth M. Park, Samrat T. Kundu, Lixia Diao, Qi Wang, Li Shen, Yuanxin Xi, Bingnan Zhang, Carminia Maria Della Corte, You-Hong Fan, Kiran Kundu, Boning Gao, Kimberley Avila, Curtis R. Pickering, Faye M. Johnson, Jianjun Zhang, Humam Kadara, John D. Minna, Don L. Gibbons, Jing Wang, John V. Heymach, Lauren A. Byers
Publicado 2021Artigo -
19
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities por Carl M. Gay, C. Allison Stewart, Elizabeth M. Park, Lixia Diao, Sarah M. Groves, Simon Heeke, Barzin Y. Nabet, Junya Fujimoto, Luisa M. Solis, Wei Lü, Yuanxin Xi, Robert J. Cardnell, Qi Wang, Giulia Fabbri, Kasey R. Cargill, Natalie I. Vokes, Kavya Ramkumar, Bingnan Zhang, Carminia Maria Della Corte, Paul Robson, Stephen G. Swisher, Jack A. Roth, Bonnie S. Glisson, David S. Shames, Ignacio I. Wistuba, Jing Wang, Vito Quaranta, John D. Minna, John V. Heymach, Lauren A. Byers
Publicado 2021Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer research
Genetics
Medicine
Gene
Internal medicine
Cell biology
Oncology
Biochemistry
Cancer
Lung cancer
Chemotherapy
Immunology
Endocrinology
PARP inhibitor
Poly ADP ribose polymerase
Polymerase
Cell
Cell culture
Cell growth
Chemistry
Cisplatin
DNA
DNA damage
Immune system
Immunotherapy
Pharmacology
Signal transduction
Biomarker
Disease